Breakthrough Trial Targets Untreatable Cancers with PMR-116
Australian researchers launch a pioneering trial using PMR-116 to tackle MYC-driven cancers, redefining precision oncology and offering fresh hope.
Trial
Read More
China’s Invasive BCI Trial Brings New Hope
China’s clinical trial of an invasive BCI marks breakthrough progress in neural tech and offers renewed hope for motor-impaired patients.
Circuit Trial Innovation Redefines Cross-Border Disputes
Shanghai’s CICC pioneers a circuit trial that redefines cross-border dispute resolution on the Chinese mainland.